Literature DB >> 24731541

The cannabinoid acids, analogs and endogenous counterparts.

Sumner H Burstein1.   

Abstract

The cannabinoid acids are a structurally heterogeneous group of compounds some of which are endogenous molecules and others that are metabolites of phytocannabinoids. The prototypic endogenous substance is N-arachidonoyl glycine (NAgly) that is closely related in structure to the cannabinoid agonist anandamide. The most studied phytocannabinoid is Δ(9)-THC-11-oic acid, the principal metabolite of Δ(9)-THC. Both types of acids have in common several biological actions such as low affinity for CB1 anti-inflammatory activity and analgesic properties. This suggests that there may be similarities in their mechanism of action, a point that is discussed in this review. Also presented are reports on analogs of the acids that provide opportunities for the development of novel therapeutic agents, such as ajulemic acid.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ajulemic acid; Cannabinoid; Lipoamino acid; Lipoxin; NAgly; Prostaglandin; Δ(9)-THC-11-oic acid

Mesh:

Substances:

Year:  2014        PMID: 24731541      PMCID: PMC4351512          DOI: 10.1016/j.bmc.2014.03.038

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  105 in total

1.  Pain reduction and lack of psychotropic effects with ajulemic acid: comment on the article by Sumariwalla et al.

Authors:  Sumner Burstein; Robert B Zurier
Journal:  Arthritis Rheum       Date:  2004-12

Review 2.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

Review 3.  PPAR-gamma: a nuclear receptor with affinity for cannabinoids.

Authors:  Sumner Burstein
Journal:  Life Sci       Date:  2005-08-19       Impact factor: 5.037

4.  Biliary excretion of delta1-tetrahydrocannabinol and its metabolites in the rat.

Authors:  M Widman; M Nordqvist; S Agurell; J E Lindgren; F Sandberg
Journal:  Biochem Pharmacol       Date:  1974-04-01       Impact factor: 5.858

5.  Prostaglandins and cannabis. XII. The effect of cannabinoid structure on the synthesis of prostaglandins by human lung fibroblasts.

Authors:  S Burstein; S A Hunter; K Ozman
Journal:  Mol Pharmacol       Date:  1983-01       Impact factor: 4.436

6.  A major metabolite of delta 1-tetrahydrocannabinol reduces its cataleptic effect in mice.

Authors:  S Burstein; S A Hunter; V Latham; L Renzulli
Journal:  Experientia       Date:  1987-04-15

7.  Prostaglandins and cannabis XV. Comparison of enantiomeric cannabinoids in stimulating prostaglandin synthesis in fibroblasts.

Authors:  S Burstein; S A Hunter; V Latham; R Mechoulam; D L Melchior; L Renzulli; R E Tefft
Journal:  Life Sci       Date:  1986-11-10       Impact factor: 5.037

8.  Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor.

Authors:  T Sheskin; L Hanus; J Slager; Z Vogel; R Mechoulam
Journal:  J Med Chem       Date:  1997-02-28       Impact factor: 7.446

Review 9.  Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation.

Authors:  Hye-Kyung Na; Young-Joon Surh
Journal:  Biochem Pharmacol       Date:  2003-10-15       Impact factor: 5.858

Review 10.  Novel endogenous N-acyl glycines identification and characterization.

Authors:  Heather B Bradshaw; Neta Rimmerman; Sherry S-J Hu; Sumner Burstein; J Michael Walker
Journal:  Vitam Horm       Date:  2009       Impact factor: 3.421

View more
  3 in total

1.  Ligand-based virtual screening identifies a family of selective cannabinoid receptor 2 agonists.

Authors:  Matteo Gianella-Borradori; Ivy Christou; Carole J R Bataille; Rebecca L Cross; Graham M Wynne; David R Greaves; Angela J Russell
Journal:  Bioorg Med Chem       Date:  2014-11-08       Impact factor: 3.641

Review 2.  Ajulemic acid: potential treatment for chronic inflammation.

Authors:  Sumner H Burstein
Journal:  Pharmacol Res Perspect       Date:  2018-04

3.  Potassium channels as molecular targets of endocannabinoids.

Authors:  Yu-Fung Lin
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.